Clinical Trials · NCT01798264
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 44
- Start date
- Feb 2009
- Locations
- 3 sites, United States
- Primary endpoint
- Number of Subjects With Study Drug-Related Adverse Events